Social Feed

Title

Image: Homerton College: University of Cambridge

Main menu

Felicity Davis

You are here

Role: 
Research Associate
Department: 
Department of Pathology
Year Joined Homerton: 
2015
Research Interests: 

Mammary gland development, breast cancer, cell signalling, calcium channels.

Qualifications: 
  • BPharm(Hons), PhD

Awards:

  • National Health and Medical Research Council (NHMRC) CJ Martin Postdoctoral Fellowship; National Institutes of Health (NIH) Postdoctoral Fellowship; ASCEPT Denis Wade Johnson and Johnson Young Investigator Award; NIEHS Martin Rodbell Award; Dean’s Award for Research Higher Degree Excellence; University Medal.

Memberships:

  • Biochemical Society, Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT), Australia and New Zealand Society for Cell and Developmental Biology (ANZSCDB)
Dissertation: 

Intracellular calcium signalling in a model of breast cancer metastasis

Publications: 
  • Azimi I, Beilby H, Davis FM, Marcial DL, Kenny PA, Thompson EW, et al. Altered purinergic receptor Ca2+ signaling associated with hypoxia-induced epithelial-mesenchymal transition in breast cancer cells. Mol Oncol (2015), [in press].
  • Davis FM, Janoshazi A, Kyathanahalli S, Steinckwich N, D’Agostin D, Petranka JG, et al. Essential role of Orai1 calcium channels in lactation. Proc Natl Acad Sci U S A (2015), 112(18):5827-32.
  • Davis FM, Stewart TA, Thompson EW, Monteith GR. Targeting EMT in cancer: opportunities for pharmacological intervention. Trends Pharmacol Sci (2014); 35(9):479-88.
  • Xing J, Petranka JG, Davis FM, Desai PN, Putney JW, Bird GS. Role of Orai1 and store-operated calcium entry in mouse lacrimal gland signaling and function. J Physiol (2014); 592:927-39.
  • Davis FM, Parsonage MT, Cabot PJ, Parat MO, Thompson EW, Roberts-Thomson SJ et al. Assessment of gene expression of intracellular calcium channels, pumps and exchangers with epidermal growth factor-induced epithelial-mesenchymal transition in a breast cancer cell line. Cancer Cell Int (2013); 13(1):76.
  • Davis FM, Azimi I, Faville RA, Peters AA, Jalink K, Putney JW, Goodhill GJ, Thompson EW et al. Induction of epithelial-mesenchymal transition (EMT) in breast cancer cells is calcium signal dependent. Oncogene (2014); 33(18):2307-16.
  • Monteith GR, Davis FM, Roberts-Thomson SJ. Calcium channels and pumps in cancer: changes and consequences. J Biol Chem (2012); 287(38):31666-73.
  • Davis FM, Peters AA, Grice DM, Cabot PJ, Parat MO, Roberts-Thomson SJ, et al. Non-stimulated, agonist-stimulated and store-operated Ca2+ influx in MDA-MB-468 breast cancer cells and the effect of EGF-induced EMT on calcium entry. PLoS ONE (2012); 7(5):e36923.
  • Davis FM, Kenny PA, Soo ET-L, van Denderen BJW, Thompson EW, Cabot PJ, Parat MO, et al. Remodeling of purinergic receptor-mediated Ca2+ signaling as a consequence of EGF-induced epithelial-mesenchymal transition in breast cancer cells. PLoS ONE (2011); 6(8):e23464.
  • Lee JM, Davis FM, Roberts-Thomson SJ, Monteith GR. Remodeling of Ca2+ signaling in tumorigenesis: the role of Ca2+ transport. Am J Physiol-Cell Physiol (2011); 301(5):C969-76.
  • McAndrew D, Grice DM, Peters AA, Davis FM, Stewart T, Rice M, Smart CE et al. ORAI1-mediated calcium influx in lactation and in breast cancer. Mol Cancer Ther (2011);10:448-60.

Report Webpage Issues:

(Only required if you wish for a reply to the report)

Information provided by you in this form will be processed for the sole purpose of remedying the issue found in relation to the website. Once complete your personal information will be deleted. If you provide an email address and request us to update you on the issue, we will contact you once to inform you when the issue is resolved.